Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells.
about
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
P2860
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Antiproliferative effect of AS ...... dependent breast cancer cells.
@en
type
label
Antiproliferative effect of AS ...... dependent breast cancer cells.
@en
prefLabel
Antiproliferative effect of AS ...... dependent breast cancer cells.
@en
P2093
P50
P356
P1476
Antiproliferative effect of AS ...... dependent breast cancer cells.
@en
P2093
Davide Prosperi
Maria Rosaria Marinozzi
Paolo Verderio
P304
P356
10.1021/MP500222K
P407
P50
P577
2014-07-18T00:00:00Z